Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 408

Sort by

Sort Order Select

Journal Articles

Optimal Use of Thai Sinlek Rice (IR) Provides the Nutraceutical Effect on Erythropoiesis in Rats

Pimpisid Koonyosying, PhD, Ben Flemming, BSc, Supachai Ekwattanakit, PhDMD, Vip Viprakasit, MD DPhil, Suthat Fucharoen, MD, Somdet Srichairatanakool, PhD

Blood (2019) 134 (Supplement_1): 4808.

https://doi.org/10.1182/blood-2019-129679

Published: 2019

Journal Articles

Mitigation of Vascular Permeability Using Bradykinin Receptor Antagonist and Anti-Fibrinolytic Agent in Rats with Polytrauma and Hemorrhagic Shock

Xiaowu Wu, MD MSc, Daniel N. Darlington, PhD, Josue Garciamarcano, Bin Liu, BS, Jeffrey D Keesee, BS, James Bynum, PhD, Andrew P. Cap, MD PhD

Blood (2019) 134 (Supplement_1): 2345.

https://doi.org/10.1182/blood-2019-130278

Published: 2019

Journal Articles

Microglia-like Cells Derived from Hematopoietic Stem and Progenitor Cells Are a Model System to Investigate Chronic Pain in Sickle Cell Disease

Yankai Zhang, PhD, Celeste K. Kanne, BA, Jennifer N. Tran, DO, Michael J. Lacagnina, PhD, Peter M. Grace, PhD, Vivien A. Sheehan, MD PhD

Blood (2019) 134 (Supplement_1): 3575.

https://doi.org/10.1182/blood-2019-128921

Published: 2019

Journal Articles

ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells

Håkan Mellstedt, MD PhD Prof., Amineh Ghaderi, MSc, Johanna Aschan, MSc, Fariba Mozaffari, MSc,PhD, Ali Moshfegh, MSc,PhD, Birgitta Sander, MD PhD Prof., Johan Schultz, MSc,PhD, Martin Norin, MSc,PhD, Thomas Olin, MSc,PhD, Elias Drakos, MD PhD Prof., George Z. Rassidakis, MD PhD Prof., Anders Österborg, MD PhD, Mohammad Hojjat-Farsangi, MSc,PhD

Blood (2019) 134 (Supplement_1): 5312.

https://doi.org/10.1182/blood-2019-129773

Published: 2019

Journal Articles

Peripheral Neuropathy and Hypovitaminosis D Are Associated in Multiple Myeloma Patients

Berdien Oortgiesen, Hans Kroes, Petra Scholtens, Jitske Hoogland, Pauline Dannenberg-de Keijzer, Claire Siemes, MD PhD, Frank Jansman, Robby Kibbelaar, Dr., Nic Veeger, Dr., Mels Hoogendoorn, Dr., Eric van Roon, Prof. Dr.

Blood (2019) 134 (Supplement_1): 5506.

https://doi.org/10.1182/blood-2019-130611

Published: 2019

Journal Articles

Initial Characterization and Toxicology of an Nmt Inhibitor in Development for Hematologic Malignancies

Michael Weickert, John Dillberger, John R. Mackey, Paul Wyatt, David Gray, Kevin Read, Christian Li, Audrey Parenteau, Luc G. Berthiaume

Blood (2019) 134 (Supplement_1): 3362.

https://doi.org/10.1182/blood-2019-124934

Published: 2019

Journal Articles

No Increased Risk of Cataract in Immune Thrombocytopenia Adult Patients Treated with Eltrombopag. a French Nationwide Nested Case-Control Study

Margaux Lafaurie, PharmD, Bérangère Baricault, Vincent Soler, MD PhD, Myriam Cassagne, MD PhD, Laurent Sailler, MD PhD, Maryse Lapeyre-Mestre, MD PhD, Agnès Sommet, MD PhD, Guillaume Moulis, MD PhD

Blood (2019) 134 (Supplement_1): 2363.

https://doi.org/10.1182/blood-2019-124729

Published: 2019

Journal Articles

An in Vitro Study on the Role of Angiogenesis in Iron Deficiency Induced Reactive Thrombocytosis

Pedro De Alarcon, MD, Manu Gnanamony, PhD, Jessica Garcia, MD

Blood (2018) 132 (Supplement 1): 2450.

https://doi.org/10.1182/blood-2018-99-115378

Published: 2018

Journal Articles

Preclinical Evaluation of MAX-40279, a FLT3/FGFR Dual Kinase Inhibitor for Treatment of Acute Myeloid Leukemia

Yuguang Wang, PhD, Hanying Bao, MD PhD, Nong Zhang, PhD, Feilan Wang, PhD, Yunsong He, MD, Tianzhi Wu, PhD

Blood (2018) 132 (Supplement 1): 3997.

https://doi.org/10.1182/blood-2018-99-110414

Published: 2018

Journal Articles

Trauma Leads to a Rise in Intracellular cAMP and Adenylate Cyclase Activity in Rats

Daniel N Darlington, PhD, Bunyan Teng, PhD, Xiaowu Wu, MD MSc, Andrew P Cap, MD PhD

Blood (2018) 132 (Supplement 1): 1155.

https://doi.org/10.1182/blood-2018-99-114805

Published: 2018

Journal Articles

The Hypofibrinolytic Defect of Nephrotic Syndrome Is Directly Proportional to Fibrin Network Density

Amanda P. Waller, PhD, Katelyn J Wolfgang, Bryce A. Kerlin, MD

Blood (2018) 132 (Supplement 1): 1218.

https://doi.org/10.1182/blood-2018-99-119947

Published: 2018

Journal Articles

Umbilical Cord Blood Mononuclear Cells for Ex-Vivo Gene Therapy

Farid V. Bashirov, Ilnur I. Salafutdinov, PhD, Michail E. Sokolov, Andrew A. Izmailov, MD, Vage A. Markosyan, Filip O. Fadeev, Albert Rizvanov, DSc, PhD, Rustem I. Islamov

Blood (2018) 132 (Supplement 1): 5797.

https://doi.org/10.1182/blood-2018-99-113462

Published: 2018

Journal Articles

Botanical Alkyl Hydroquinone Derivative HQ17(3) Induces Calcium-Associated Mitochondrial Damage and Mitophagy to Exert Ctotoxicity to Philadelphila Chromosome(+) ALL Cells

Yin-Chen Chou, MS, Chia-Wei Chen, MS, Yuan-Yeh Kuo, PhD, Liang-In Lin, PhD, Chung-Yi Hu, PhD

Blood (2018) 132 (Supplement 1): 5800.

https://doi.org/10.1182/blood-2018-99-120307

Published: 2018

Journal Articles

A Fully Human Anti-BMP6 Antibody Reduces the Need for Erythropoietin Stimulating Agent in Two Rodent Anemia of Chronic Disease Models

Verena Petzer, MD, Piotr Tymoszuk, PhD, Matthew Wake, PhD, Luke Bayliss, BSc, Jonathan Papworth, BSc, Joana Carvalho, PhD, Cecilia Deantonio, PhD, Malte Ferdinand Asshoff, MD, Markus Seifert, Sylvia Berger, Dominik Wolf, MD, Günter Weiss, MD, Volker Germaschewski, PhD, Igor Theurl, MD PhD

Blood (2018) 132 (Supplement 1): 1045.

https://doi.org/10.1182/blood-2018-99-115747

Published: 2018

Journal Articles

Preclinical Evaluation of Safety and Biodistribution of Red Cell Microparticles (RMP): A Novel Hemostatic Agent

Ashish Rehni, PhD, Vibha Shukla, PhD, Hever Navarro-Quero, DVM, Carlos Bidot, Jr., Conner Haase, Anise Crane, Shivam Patel, Sebastian Koch, MD, Yeon S. Ahn, MD, Wenche Jy, PhD, Kunjan Dave, PhD

Blood (2018) 132 (Supplement 1): 1044.

https://doi.org/10.1182/blood-2018-99-116508

Published: 2018

Journal Articles

Development of Inhibitors of PIP4K2 As a Treatment for Patients with Hematologic Malignancies

Blood (2018) 132 (Supplement 1): 213.

https://doi.org/10.1182/blood-2018-99-118355

Published: 2018

Journal Articles

The Severe Spontaneous Bleeding Phenotype in a Novel Hemophilia a Rat Model with an Inversion Mutation Is Rescued By Platelet-Targeted FVIII Expression

Qizhen Shi, MD, Jeremy G Mattson, Scot A Fahs, Robert R Montgomery, MD

Blood (2018) 132 (Supplement 1): 219.

https://doi.org/10.1182/blood-2018-99-112165

Published: 2018

Journal Articles

KRX-101, a Novel FLT3 Inhibitor, Potently Active Against Resistant FLT3 -ITD/ FLT3 -TKD Mutant AML in Vitro and In Vivo

Herman O Sintim, PhD, M. Javad Aman, PhD, Frederick Holtsberg, PhD, Ashkan Emadi, MD PhD, Rena G Lapidus, PhD

Blood (2018) 132 (Supplement 1): 4049.

https://doi.org/10.1182/blood-2018-99-115260

Published: 2018

Journal Articles

A Novel HCK Inhibitor Kin-8193 Blocks BTK Activity in BTK Cys481 Mutated Ibrutinib Resistant B-Cell Lymphomas Driven By Mutated MYD88

Guang Yang, PhD, Jinhua Wang, PhD, Li Tan, PhD, Xia Liu, MD, Manit Munshi, MS, Jiaji G Chen, Lian Xu, MS, Nickolas Tsakmaklis, Maria Demos, Amanda Kofides, Maria Luisa Guerrera, MD, Gloria G Chan, MS, Zachary R Hunter, PhD, Christopher Patterson, MAcc, Jorge J. Castillo, MD, Sara J Buhrlage, PhD, Nathanael S. Gray, PhD, Steven P Treon, MD PhD FRCP

Blood (2018) 132 (Supplement 1): 40.

https://doi.org/10.1182/blood-2018-99-119171

Published: 2018

Journal Articles

Absence of Plasma Gastric Biomarker Elevations with Chronic Dosing of Avatrombopag, a Novel Oral Thrombopoietin Receptor Agonist, in Patients with Chronic Immune Thrombocytopenia in Phase 3 Trials

James B. Bussel, MD, Lee F. Allen, MD PhD, Wei Tian, PhD, David J. Kuter, MD DPhil

Blood (2018) 132 (Supplement 1): 3740.

https://doi.org/10.1182/blood-2018-99-116873

Published: 2018

NARROW

Optimal Use of Thai Sinlek Rice (IR) Provides the Nutraceutical Effect on Erythropoiesis in Rats

Mitigation of Vascular Permeability Using Bradykinin Receptor Antagonist and Anti-Fibrinolytic Agent in Rats with Polytrauma and Hemorrhagic Shock

Microglia-like Cells Derived from Hematopoietic Stem and Progenitor Cells Are a Model System to Investigate Chronic Pain in Sickle Cell Disease

ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells

Peripheral Neuropathy and Hypovitaminosis D Are Associated in Multiple Myeloma Patients

Initial Characterization and Toxicology of an Nmt Inhibitor in Development for Hematologic Malignancies

No Increased Risk of Cataract in Immune Thrombocytopenia Adult Patients Treated with Eltrombopag. a French Nationwide Nested Case-Control Study

An in Vitro Study on the Role of Angiogenesis in Iron Deficiency Induced Reactive Thrombocytosis

Preclinical Evaluation of MAX-40279, a FLT3/FGFR Dual Kinase Inhibitor for Treatment of Acute Myeloid Leukemia

Trauma Leads to a Rise in Intracellular cAMP and Adenylate Cyclase Activity in Rats

The Hypofibrinolytic Defect of Nephrotic Syndrome Is Directly Proportional to Fibrin Network Density

Umbilical Cord Blood Mononuclear Cells for Ex-Vivo Gene Therapy

Botanical Alkyl Hydroquinone Derivative HQ17(3) Induces Calcium-Associated Mitochondrial Damage and Mitophagy to Exert Ctotoxicity to Philadelphila Chromosome(+) ALL Cells

A Fully Human Anti-BMP6 Antibody Reduces the Need for Erythropoietin Stimulating Agent in Two Rodent Anemia of Chronic Disease Models

Preclinical Evaluation of Safety and Biodistribution of Red Cell Microparticles (RMP): A Novel Hemostatic Agent

Development of Inhibitors of PIP4K2 As a Treatment for Patients with Hematologic Malignancies

The Severe Spontaneous Bleeding Phenotype in a Novel Hemophilia a Rat Model with an Inversion Mutation Is Rescued By Platelet-Targeted FVIII Expression

KRX-101, a Novel FLT3 Inhibitor, Potently Active Against Resistant FLT3 -ITD/ FLT3 -TKD Mutant AML in Vitro and In Vivo

A Novel HCK Inhibitor Kin-8193 Blocks BTK Activity in BTK Cys481 Mutated Ibrutinib Resistant B-Cell Lymphomas Driven By Mutated MYD88

Absence of Plasma Gastric Biomarker Elevations with Chronic Dosing of Avatrombopag, a Novel Oral Thrombopoietin Receptor Agonist, in Patients with Chronic Immune Thrombocytopenia in Phase 3 Trials

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only